Udayavni Special

Our COVID-19 vaccine can remain stable at 5°C for at least 3 months: CureVac


Team Udayavani, Nov 13, 2020, 10:00 AM IST

German biopharmaceutical company CureVac said its experimental COVID-19 vaccine can remain stable at 5°C for at least three months. Tests also established stability at room temperature for up to 24 hours, CureVac said on Thursday.

The company said that this quality makes its vaccine potentially easier to distribute than some rivals’ vaccines as it is suitable for standard fridge transport.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

COVID-19 vaccine to be first given to about 1 cr health workers: Govt at all-party meet

Malaika multi-state credit society scam: Four top office-bearers held for duping investors

Maharashtra Teacher Wins $1 Million, Says Will Share Half With Finalists

War of words between CSE, FSSAI over adulterated honey sold by major brands in India

By when will every Indian get free COVID vaccine, Rahul Gandhi asks PM Modi

Hooliganism will not be allowed in Shivamogga: Eshwarappa

Met dept withdraws red alert for 7 Kerala districts as cyclone Burevi weakens



Related Articles More

Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy

COVID-19 caseload in India rises to 95.71 lakh with 36,595 new infections

K’taka COVID-19 update: 1446 new cases, 894 discharges, 13 dead on Dec 2

5 Covid-19 Vaccines Undergoing Trial in India Logistically Feasible for Distribution in Both Urban, Rural Areas: AIIMS Director

Committed to engaging with Indian govt to make vaccine available in country: Pfizer

MUST WATCH

Hamsa Chaitanya Desi Outlet | Desi Products Store Udupi | Documentary by Udayavani

Pro-terror graffiti case culprits will be arrested soon: Basavaraj Bommai

Meal of Bakasur : Hotel Fish Campus Udupi | Udayavani

Things You Should Know When Starting A Business | Profitable Business Ideas After Lockdown

Mangalore Boat tragedy: We’re with families of deceased, says Kota after announcing Rs 6 lakh compensation

Latest Additions

Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy

Joe Biden Taps Indian-American Vivek Murthy as Surgeon General: Report

15-yr-old Indian-American Gitanjali Rao named first ‘TIME Kid of the Year’

COVID-19 vaccine to be first given to about 1 cr health workers: Govt at all-party meet

Malaika multi-state credit society scam: Four top office-bearers held for duping investors

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.